CALCA and migraine disorder: A real-world study showed that anti-CGRP drugs could induce or aggravate Raynaud’s phenomenon with a significantly stronger signal than triphenylamine, which is a migraine drug that can induce the Raynaud phenomenon (Gerard et al., 2022).